Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation

ORAN, İSMAİL; ÇINAR, CELAL; BOZKAYA, HALİL; KORKMAZ, MEHMET

doi:10.1136/neurintsurg-2013-011023

Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation

Copy For Citation

ORAN İ., ÇINAR C., BOZKAYA H., KORKMAZ M.

JOURNAL OF NEUROINTERVENTIONAL SURGERY, vol.7, no.5, pp.357-362, 2015 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 7 Issue: 5
Publication Date: 2015
Doi Number: 10.1136/neurintsurg-2013-011023
Title of Journal : JOURNAL OF NEUROINTERVENTIONAL SURGERY
Page Numbers: pp.357-362

Abstract

Background and purpose Pretreatment with dual antiaggregant drugs is accepted as a standard step in intracranial stent implantation. The aim of this study was to determine whether tailored antiaggregant medication based on platelet reactivity testing with multiple electrode aggregometry (Multiplate) yields superior outcomes after intracranial flow-diverting stent (FDS) implantation compared with standard clopidogrel treatment.